Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

16 Aug 2010 08:50

RNS Number : 1119R
Phorm Inc
16 August 2010
 



16th August 2010

Phorm, Inc. ('Phorm' or 'the Company')

 

Phorm Announces Board Changes

 

Phorm (AIM: PHRM and PHRX), the internet personalisation technology company, announces the following changes to the Company's Board:

 

Mark Schneider is appointed to the Board as a Non-Executive Director. Mark was co-founder of leading European cable group UPC, which was subsequently acquired by Liberty Global in 2005. Mark has served on public and private company boards of companies operating in over 20 countries around the world, including United Artist Entertainment, UIH, UnitedGlobalCom, UPC, SBS Broadcasting and Blockbuster Video. With his background in international cable and telecommunications, Mark brings strong operating knowledge and an extensive network of contacts to the Board.

 

Kip Meek will step down from the Board with immediate effect. This follows Kip's previously announced appointment as Chairman of Project Canvas.

 

Kent Ertugrul, CEO of Phorm, commented, "I would like to thank Kip for his valuable insights and advice, which have contributed to the progress made by the Company since his appointment. We are sorry to see Kip go, but recognise that he needs to focus his energies on Project Canvas. We wish him well.

 

Meanwhile, we welcome Mark Schneider to the Board. He brings with him an in-depth understanding of media and telecommunications, has operated in multiple markets globally, and remains one of the pioneers of the international cable industry. We look forward to working with Mark to deliver on the substantial promise of our Company."

 

Save as set out in the Appendix, there are no further details in relation to the above appointment which require disclosure under paragraph (g) of Schedule 2 to the AIM rules.

 

Enquiries:

 

Phorm, Inc

Sarah Simon: +44 20 7297 2433 (analysts and investors)

Alex Laity: +44 20 7297 2710 (press)

 

Citigate Dewe Rogerson +44 20 7638 9571

Simon Rigby

Justin Griffiths

 

Canaccord Genuity Limited +44 20 7050 6500

(Nominated Adviser)

Mark Williams

Andrew Chubb

 

 

Appendix:

 

Information provided in accordance with paragraph g of Schedule 2 to the AIM rules:

 

1. Details of full name, age, previous names:

 

Full Name: Mark Lyle Schneider

Age: 55

 

2. Names of all companies and partnerships of which the director has been a director or partner at any time in the previous five years, indicating whether or not the director is still a director or partner

 

General Media Services Limited - present

Schneider Media Africa Limited - present

Africa Telecommunications Media and Technology Fund 1 LLC - present

Big Sleep Hotels - present

Ricall Limited - present

Shorts Entertainment Limited - present

 

In addition, Mr Schneider has, in relation to this appointment as a Non-Executive Director, today been granted options over 150,000 shares of USD 0.001 each in the Company ("Ordinary Shares"), exercisable at a price of 137.5p per Ordinary Share. These options have a vesting period of four years, and expire ten years from the Date of Grant. Following this grant, Mr Schneider will have options over 200,000 Ordinary Shares.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADMGMRNVLGGZG
Date   Source Headline
14th Apr 201610:00 amRNSUpdate and Resignation of Nominated Adviser
16th Mar 201612:37 pmRNSIssue of US$500,000 of Convertible Loan Notes
16th Mar 20167:00 amRNSIssue of US$500,000 of Convertible Loan Notes
25th Feb 20168:02 amRNSFunding Update and Statement re Suspension
25th Feb 20167:55 amRNSSuspension - Phorm Corporation Limited
4th Feb 20166:05 pmRNSFunding Update
1st Feb 20163:49 pmRNSSubscription Update, New Subscription & Loan
21st Jan 20167:00 amRNSPhorm Awarded TRUSTe Certified Privacy Seal
18th Jan 20167:00 amRNSSubscription & Operational Update
5th Jan 20162:00 pmRNSTR-1: Notification of major interest in shares
23rd Dec 20151:00 pmRNSRevised Non-Executive Director Compensation
22nd Dec 20157:00 amRNSDirectorate Change
7th Dec 20157:00 amRNSRepricing of Options
3rd Dec 201511:00 amRNSPhorm Enables Hover Rate with Insomnis Media
1st Dec 20157:00 amRNSNew Share Option Plan and Grant of Options
18th Nov 20157:00 amRNSTR-1: Notifications of Major Interests in Shares
28th Oct 20157:00 amRNSPartnering Agreement with INSOMNIS Media Limited
20th Oct 20157:00 amRNSAgreement with Causemo, Inc.
13th Oct 20157:00 amRNSPhorm Hires Chief Revenue Officer
9th Oct 20157:00 amRNSAgreement with Boston Globe Media Group
30th Sep 20151:33 pmRNSInterim Results
28th Aug 20152:38 pmRNSResult of AGM
10th Aug 20157:00 amRNSNotice of Annual General Meeting
7th Aug 20157:48 amRNSEquity fundraising of approximately £3.2 million
29th Jul 20157:02 amRNSUpdate re Board Changes
28th Jul 20157:00 amRNSLoan Agreement & Convertible Loan Note Extension
15th Jul 201511:21 amRNSBoard and Management Changes
3rd Jul 20157:00 amRNSOperational Update
2nd Jul 20157:16 amRNSDirectorate Change
30th Jun 20157:00 amRNSAnnual Financial Report
8th May 20154:00 pmRNSTR-1: Notification of major interest in shares
22nd Apr 20157:00 amRNSEquity Fundraising of £6.0 million Gross
21st Apr 20154:22 pmRNSOperational Update
16th Mar 20153:45 pmRNSDirectorate Change
25th Feb 20157:02 amRNSBoard Changes
19th Jan 20157:00 amRNSEquity fundraising of approximately £6.25 million
16th Jan 20157:21 amRNSOperational Update
8th Dec 20147:00 amRNSEquity Fundraising
28th Oct 20147:00 amRNSTR-1: Notification of major interest in shares
8th Oct 20147:00 amRNSEquity fundraising of £4.47 million
6th Oct 20147:00 amRNSOperational Update
22nd Aug 20147:05 amRNSSubscription To Raise £2.4 million
22nd Aug 20147:00 amRNSInterim Results
24th Jul 20142:31 pmRNSResult of Annual General Meeting
27th Jun 20147:30 amRNSGlobal Operations Update
27th Jun 20147:05 amRNSNotice of Annual General Meeting and Board Changes
27th Jun 20147:00 amRNSFinal Results for the Year Ended 31 December 2013
23rd Apr 20144:25 pmRNSTR-1: Notification of major interest in shares
14th Apr 201412:40 pmRNSResult of EGM
27th Mar 20147:00 amRNSProposed £10m Placing & Notice of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.